What is it about?
In vitro and in vivo studies about the potential of EPS to influence immune cell response and modulate murine allergic airway responses
Featured Image
Why is it important?
EPS-treatment reduced eosinophil recruitment within the lung in a respiratory inflammation mouse model, which is both TLR-2 and IL-10 mediated.
Perspectives
EPS can be considered as a novel molecule potentially reducing the severity of chronic eosinophil-related airway disorders.
Elisa Schiavi
University La Sapienza, Rome
Read the Original
This page is a summary of: Exopolysaccharide from Bifidobacterium longum subsp. longum 35624™ modulates murine allergic airway responses, Beneficial Microbes, September 2018, Wageningen Academic Publishers,
DOI: 10.3920/bm2017.0180.
You can read the full text:
Contributors
The following have contributed to this page
